Ian Pardo is a highly experienced EU/UK Pharmaceutical Qualified Person (QP) with two decades of expertise in pharmaceutical manufacture and quality.

As a former Senior Pharmaceutical Assessor at the MHRA, Dima provided scientific advice to developers and assessed UK/EU marketing authorisations. 

With over 20 years experience in leading successful regulatory outcomes, Christine advises on how to get the best out of scientific advice meetings with regulators and navigate the complexities of the global regulatory environment.

Dr. Dmitry Zamoryakhin brings over 20 years of expertise in global drug development, with a specialization in rare diseases, oncology, and precision medicine.

As the founder of patientRx Ltd., he is committed to making clinical trials more patient-centric whilst ensuring trials meet scientific, operational and commercial objectives.

With 25 years experience assessing clinical trial and license applications at MHRA, David is ideally positioned to advise on what it takes to move your innovation into the clinic or likely questions from Regulators on your nonclinical data package.

Dr. Jörg Herbst is an experienced Nonclinical Safety Expert with > 25 years of firsthand experience in the biopharmaceutical industry and expertise in gene therapy.